Highlights Biomark Diagnostics Inc.

Equities

20B

CA09073K1084

Market Closed - Deutsche Boerse AG Other stock markets 11:46:22 20/05/2024 am IST			5-day change	1st Jan Change
0.138 ^EUR	-16.36%		-2.82%	-6.12%

29/02	Biomark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
28/02	BioMark Diagnostics Inc. Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biomark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01/03	CI
BioMark Diagnostics Inc. Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities	28/02	CI
BioMark Announces New Patent Granted in Canada For Liquid Biopsy Based Legacy Assay	05/12	MT
Biomark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	28/11	CI
Biomark Diagnostics Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	28/23/28	CI
Biomark Diagnostics Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	01/23/01	CI
BioMark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	28/23/28	CI
BioMark Diagnostics Inc. Announces Update from Ongoing Clinical Trial Using its Lung Cancer Liquid Biopsy Test as it Prepares for Commercial Launch	11/23/11	CI
BioMark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	25/22/25	CI
Biomark's Glioblastoma Study Published in Cancers Demonstrates Inhibiting SAT1 Sensitized Cancer Cells Towards Radiation and Chemotherapy	27/22/27	CI
BioMark Diagnostics Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022	30/22/30	CI
BioMark Diagnostics Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	12/22/12	CI
BioMark Diagnostics and the Icahn School of Medicine At Mount Sinai Announce Partnership to Advance Early Lung Cancer	07/22/07	CI
BioMark Diagnostics Inc. Announces Update on Company Outlook for 2022	01/22/01	CI
BioMark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	01/22/01	CI
BioMark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	24/21/24	CI
Biomark Diagnostics Inc Reports Earnings Results for the Full Year Ended March 31, 2021	14/21/14	CI
Biomark Diagnostics Inc to Expand Treatment Response Trial to Advanced Lung Cancer Patients Receiving Immunotherapy	29/21/29	CI
Biomark Diagnostics Inc Reports Earnings Results for the Third Quarter Ended December 31, 2020	27/21/27	CI
BioMark Diagnostics Inc.'s Subsidiary BioMark Diagnostic Solutions Inc. Enters into Collaborative Research and Development Agreement with Phytronix Technologies Inc	16/21/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Biomark Diagnostics Inc.

Equities

20B

CA09073K1084

Highlights

Filters